GUILFORD, Conn. — Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” or the “Company”), a life sciences tools company commercializing a single molecule protein sequencing platform, today announced that management will discuss the following business updates at the 40th Annual J.P. Morgan Healthcare Conference. Commercial update Quantum-Si has established list prices for its end-to-end protein sequencing platform as follows: $70,000 […]
AMSBIO has announced new additions to its portfolio of tools for COVID-19 research – two monoclonal antibodies that recognize the Spike RBD (B.1.1.529, Omicron Variant) protein and neutralizes its interaction with ACE2. The human ACE2 receptor is found on the surface of type I and II pneumocytes, endothelial cells, and ciliated bronchial epithelial cells. Research has shown that ACE2 mediates COVID-19 infection […]
Delivery of 100,000 samples of capacity annually to the market, empowering genomics researchers to add deep, unbiased proteomics analysis to their studies REDWOOD CITY, Calif. and HUNTSVILLE, Ala. and FRAMINGHAM, Mass. — Seer Inc. (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics; SCIEX, a global leader in life science analytical […]
Chad Brown to Retire Following More than Four Successful Years as SVP, Sales & Marketing Genomics and Diagnostics Veteran John D. Gerace Appointed as Chief Commercial Officer SEATTLE — NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced a commercial leadership transition. Chad Brown, who has […]
Superhero cells are key to the efficacy, potency, and durability of therapies across the human health spectrum BRANFORD, Conn. — IsoPlexis (NASDAQ: ISO), the Superhuman Cell Company, today announced its preliminary unaudited revenue for the full year 2021. Total revenue for 2021 is expected to be in the range of $17.0 to $17.2 million, representing an increase of […]
ROCKVILLE, Md. — OriGene updates its logo, signifying its evolvement from genomic to proteomic market. The logo modification includes an addition of antibody/antigen image to the previous logo, highlighting the expansion of OriGene’s product portfolio from genomic (plasmids/RNAi/PCR) to proteomic (protein/antibody/assays). In the past 25 years, OriGene has dedicated to creation of the world’s largest source of […]
— Results independently confirmed through live virus plaque-reduction assay — — Results published on BioRxiv and submitted to the FDA as part of pre-IND data package — BETHESDA, Md. & SOUTH SAN FRANCISCO, Calif. — Revelar Biotherapeutics, Inc. and Twist Bioscience Corporation (Nasdaq: TWST) today announced that RBT-0813 binds to and neutralizes the Omicron and Delta […]
Partnership will Accelerate Next-Generation Sequencing into Fastest-Growing Area of Proteomics Market with Ultra-high Throughput, Ultra-high Plexity Workflow SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) today announced it has entered into a definitive co-development agreement with SomaLogic to bring the SomaScan® Proteomics Assay onto Illumina’s current and future high throughput next-generation sequencing (NGS) platforms. This partnership […]
Co-developed and co-branded products to combine market-leading proteomic and genomic analysis platforms BOULDER, Colo. — SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced a worldwide strategic collaboration with Illumina, a global next-generation sequencing technology leader. The multi-year partnership agreement will bring together genomics and proteomics technology platforms in a major commercial partnership […]
EMBER500™ RNA Prestain Loading Dye allows single-step denaturing, loading, and bright RNA staining on regular agarose gels Fremont, CA – Life Science Newswire – Biotium, inventor of the popular GelRed® and GelGreen® DNA gel stains, announces the release of EMBER500™ RNA Prestain Loading Dye. This novel prestain loading dye is much more sensitive than conventional […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
